The use of broad- or dual-based antibiotic regimens in the perioperative management of patients undergoing nipple-sparing mastectomy and reconstruction appears to offer no benefit over single-agent regimens in reducing surgical site infections, according to new research presented at the 2021 annual meeting of the American Society of Breast Surgeons.
Perioperative antibiotic coverage is recommended in patients undergoing mastectomy and reconstruction to avoid ssI, but there are questions about